nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—ALB—epilepsy syndrome	0.28	1	CbGaD
Sodium lauryl sulfate—ALB—Oxcarbazepine—epilepsy syndrome	0.105	0.205	CbGbCtD
Sodium lauryl sulfate—ALB—Fosphenytoin—epilepsy syndrome	0.0922	0.179	CbGbCtD
Sodium lauryl sulfate—ALB—Clonazepam—epilepsy syndrome	0.0834	0.162	CbGbCtD
Sodium lauryl sulfate—ALB—Rufinamide—epilepsy syndrome	0.068	0.132	CbGbCtD
Sodium lauryl sulfate—ALB—Phenytoin—epilepsy syndrome	0.0594	0.116	CbGbCtD
Sodium lauryl sulfate—ALB—Propofol—epilepsy syndrome	0.0554	0.108	CbGbCtD
Sodium lauryl sulfate—ALB—Diazepam—epilepsy syndrome	0.0502	0.0976	CbGbCtD
Sodium lauryl sulfate—Decamethonium—CHRNA2—epilepsy syndrome	0.00179	0.41	CrCbGaD
Sodium lauryl sulfate—Decamethonium—HRH3—epilepsy syndrome	0.0014	0.321	CrCbGaD
Sodium lauryl sulfate—ALB—Transport of organic anions—SLCO1A2—epilepsy syndrome	0.00119	0.0776	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Recycling of bile acids and salts—SLCO1A2—epilepsy syndrome	0.000881	0.0575	CbGpPWpGaD
Sodium lauryl sulfate—Decamethonium—CHRM2—epilepsy syndrome	0.000639	0.147	CrCbGaD
Sodium lauryl sulfate—ALB—Transport of vitamins, nucleosides, and related molecules—SLC35A2—epilepsy syndrome	0.000582	0.038	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transport of vitamins, nucleosides, and related molecules—SLC35A3—epilepsy syndrome	0.000582	0.038	CbGpPWpGaD
Sodium lauryl sulfate—Decamethonium—BCHE—epilepsy syndrome	0.000533	0.122	CrCbGaD
Sodium lauryl sulfate—ALB—Bile acid and bile salt metabolism—SLCO1A2—epilepsy syndrome	0.000461	0.0301	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transport of vitamins, nucleosides, and related molecules—SLCO1A2—epilepsy syndrome	0.000441	0.0288	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—FOLR1—epilepsy syndrome	0.00042	0.0274	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Bile acid and bile salt metabolism—HSD17B4—epilepsy syndrome	0.000405	0.0265	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—SEPW1—epilepsy syndrome	0.000392	0.0256	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transport of vitamins, nucleosides, and related molecules—APOD—epilepsy syndrome	0.000343	0.0224	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transport of organic anions—AVP—epilepsy syndrome	0.000342	0.0223	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet degranulation—LAMP2—epilepsy syndrome	0.000293	0.0191	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—LAMP2—epilepsy syndrome	0.00028	0.0182	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—PNPO—epilepsy syndrome	0.000272	0.0177	CbGpPWpGaD
Sodium lauryl sulfate—ALB—FOXA2 and FOXA3 transcription factor networks—KCNJ11—epilepsy syndrome	0.000215	0.014	CbGpPWpGaD
Sodium lauryl sulfate—ALB—HDL-mediated lipid transport—APOE—epilepsy syndrome	0.000207	0.0135	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet degranulation—FLNA—epilepsy syndrome	0.000147	0.00961	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—TXNRD1—epilepsy syndrome	0.000141	0.00917	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—FLNA—epilepsy syndrome	0.00014	0.00916	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—LAMP2—epilepsy syndrome	0.00013	0.00849	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—PLAT—epilepsy syndrome	0.000129	0.00842	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—epilepsy syndrome	0.000127	0.00828	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.000125	0.00815	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.000125	0.00815	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.000125	0.00815	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Lipoprotein metabolism—APOE—epilepsy syndrome	0.000119	0.00774	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet degranulation—PPIA—epilepsy syndrome	0.000116	0.00756	CbGpPWpGaD
Sodium lauryl sulfate—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000115	0.00062	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000115	0.00062	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000115	0.00062	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Propofol—epilepsy syndrome	0.000115	0.000618	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000114	0.00746	CbGpPWpGaD
Sodium lauryl sulfate—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000114	0.000615	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Diazepam—epilepsy syndrome	0.000114	0.000615	CcSEcCtD
Sodium lauryl sulfate—Rash—Propofol—epilepsy syndrome	0.000114	0.000613	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Propofol—epilepsy syndrome	0.000114	0.000612	CcSEcCtD
Sodium lauryl sulfate—Headache—Propofol—epilepsy syndrome	0.000113	0.000609	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000113	0.000607	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Midazolam—epilepsy syndrome	0.000112	0.000604	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000112	0.000604	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Felbamate—epilepsy syndrome	0.000112	0.000604	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Pregabalin—epilepsy syndrome	0.000112	0.000603	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Valproic Acid—epilepsy syndrome	0.000112	0.000603	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Valproic Acid—epilepsy syndrome	0.000112	0.000601	CcSEcCtD
Sodium lauryl sulfate—Rash—Midazolam—epilepsy syndrome	0.000111	0.000599	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Fosphenytoin—epilepsy syndrome	0.000111	0.000599	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Midazolam—epilepsy syndrome	0.000111	0.000599	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Carbamazepine—epilepsy syndrome	0.000111	0.000598	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Levetiracetam—epilepsy syndrome	0.000111	0.000597	CcSEcCtD
Sodium lauryl sulfate—Headache—Midazolam—epilepsy syndrome	0.000111	0.000595	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Felbamate—epilepsy syndrome	0.000111	0.000595	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Carbamazepine—epilepsy syndrome	0.00011	0.000595	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Carbamazepine—epilepsy syndrome	0.00011	0.000595	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Diazepam—epilepsy syndrome	0.00011	0.000595	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.00011	0.000595	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—PPIA—epilepsy syndrome	0.00011	0.0072	CbGpPWpGaD
Sodium lauryl sulfate—Rash—Levetiracetam—epilepsy syndrome	0.00011	0.000592	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Levetiracetam—epilepsy syndrome	0.00011	0.000591	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Zonisamide—epilepsy syndrome	0.00011	0.000591	CcSEcCtD
Sodium lauryl sulfate—Headache—Levetiracetam—epilepsy syndrome	0.000109	0.000588	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000109	0.000585	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Vigabatrin—epilepsy syndrome	0.000108	0.000584	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Zonisamide—epilepsy syndrome	0.000108	0.000583	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000108	0.000581	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Gabapentin—epilepsy syndrome	0.000107	0.000579	CcSEcCtD
Sodium lauryl sulfate—Oedema—Valproic Acid—epilepsy syndrome	0.000107	0.000578	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000107	0.000578	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Lamotrigine—epilepsy syndrome	0.000107	0.000578	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000107	0.000578	CcSEcCtD
Sodium lauryl sulfate—Nausea—Propofol—epilepsy syndrome	0.000107	0.000577	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Fosphenytoin—epilepsy syndrome	0.000107	0.000576	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Felbamate—epilepsy syndrome	0.000107	0.000576	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000107	0.000575	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000107	0.000575	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Gabapentin—epilepsy syndrome	0.000107	0.000575	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Diazepam—epilepsy syndrome	0.000107	0.000575	CcSEcCtD
Sodium lauryl sulfate—Infection—Valproic Acid—epilepsy syndrome	0.000107	0.000574	CcSEcCtD
Sodium lauryl sulfate—Syncope—Pregabalin—epilepsy syndrome	0.000107	0.000574	CcSEcCtD
Sodium lauryl sulfate—Rash—Fosphenytoin—epilepsy syndrome	0.000106	0.000571	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000106	0.000571	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Clonazepam—epilepsy syndrome	0.000106	0.00057	CcSEcCtD
Sodium lauryl sulfate—Headache—Fosphenytoin—epilepsy syndrome	0.000105	0.000568	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Pregabalin—epilepsy syndrome	0.000105	0.000566	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Phenytoin—epilepsy syndrome	0.000105	0.000566	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—PLAT—epilepsy syndrome	0.000105	0.00685	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Midazolam—epilepsy syndrome	0.000105	0.000565	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000105	0.000565	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Valproic Acid—epilepsy syndrome	0.000105	0.000564	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Zonisamide—epilepsy syndrome	0.000105	0.000564	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000104	0.000563	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000104	0.000563	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Clonazepam—epilepsy syndrome	0.000104	0.000562	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Vigabatrin—epilepsy syndrome	0.000104	0.000561	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000104	0.000559	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Phenytoin—epilepsy syndrome	0.000104	0.000558	CcSEcCtD
Sodium lauryl sulfate—Nausea—Levetiracetam—epilepsy syndrome	0.000104	0.000558	CcSEcCtD
Sodium lauryl sulfate—Rash—Vigabatrin—epilepsy syndrome	0.000103	0.000557	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Felbamate—epilepsy syndrome	0.000103	0.000556	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000103	0.000556	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000103	0.000555	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Pregabalin—epilepsy syndrome	0.000103	0.000555	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000103	0.000555	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Gabapentin—epilepsy syndrome	0.000103	0.000553	CcSEcCtD
Sodium lauryl sulfate—Headache—Vigabatrin—epilepsy syndrome	0.000103	0.000553	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Diazepam—epilepsy syndrome	0.000103	0.000553	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Valproic Acid—epilepsy syndrome	0.000102	0.000551	CcSEcCtD
Sodium lauryl sulfate—Rash—Diazepam—epilepsy syndrome	0.000102	0.000548	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Diazepam—epilepsy syndrome	0.000102	0.000548	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Pregabalin—epilepsy syndrome	0.000101	0.000545	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Zonisamide—epilepsy syndrome	0.000101	0.000545	CcSEcCtD
Sodium lauryl sulfate—Headache—Diazepam—epilepsy syndrome	0.000101	0.000545	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Pregabalin—epilepsy syndrome	0.000101	0.000543	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Clonazepam—epilepsy syndrome	0.000101	0.000543	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Valproic Acid—epilepsy syndrome	0.0001	0.00054	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Carbamazepine—epilepsy syndrome	0.0001	0.00054	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Phenytoin—epilepsy syndrome	0.0001	0.000539	CcSEcCtD
Sodium lauryl sulfate—Nausea—Fosphenytoin—epilepsy syndrome	9.99e-05	0.000538	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.96e-05	0.000537	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.95e-05	0.000536	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Felbamate—epilepsy syndrome	9.93e-05	0.000535	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Carbamazepine—epilepsy syndrome	9.89e-05	0.000532	CcSEcCtD
Sodium lauryl sulfate—Rash—Felbamate—epilepsy syndrome	9.85e-05	0.000531	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Felbamate—epilepsy syndrome	9.84e-05	0.00053	CcSEcCtD
Sodium lauryl sulfate—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—epilepsy syndrome	9.82e-05	0.00641	CbGpPWpGaD
Sodium lauryl sulfate—Headache—Felbamate—epilepsy syndrome	9.79e-05	0.000527	CcSEcCtD
Sodium lauryl sulfate—Syncope—Gabapentin—epilepsy syndrome	9.78e-05	0.000527	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Clonazepam—epilepsy syndrome	9.75e-05	0.000525	CcSEcCtD
Sodium lauryl sulfate—Nausea—Vigabatrin—epilepsy syndrome	9.74e-05	0.000525	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Zonisamide—epilepsy syndrome	9.72e-05	0.000524	CcSEcCtD
Sodium lauryl sulfate—Oedema—Pregabalin—epilepsy syndrome	9.7e-05	0.000523	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Pregabalin—epilepsy syndrome	9.7e-05	0.000523	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Lamotrigine—epilepsy syndrome	9.69e-05	0.000522	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Phenytoin—epilepsy syndrome	9.68e-05	0.000521	CcSEcCtD
Sodium lauryl sulfate—Rash—Zonisamide—epilepsy syndrome	9.64e-05	0.000519	CcSEcCtD
Sodium lauryl sulfate—Infection—Pregabalin—epilepsy syndrome	9.64e-05	0.000519	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Valproic Acid—epilepsy syndrome	9.64e-05	0.000519	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Gabapentin—epilepsy syndrome	9.63e-05	0.000519	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Zonisamide—epilepsy syndrome	9.63e-05	0.000519	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Oxcarbazepine—epilepsy syndrome	9.63e-05	0.000519	CcSEcCtD
Sodium lauryl sulfate—Nausea—Diazepam—epilepsy syndrome	9.59e-05	0.000516	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Gabapentin—epilepsy syndrome	9.58e-05	0.000516	CcSEcCtD
Sodium lauryl sulfate—Headache—Zonisamide—epilepsy syndrome	9.58e-05	0.000516	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Valproic Acid—epilepsy syndrome	9.57e-05	0.000515	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Carbamazepine—epilepsy syndrome	9.56e-05	0.000515	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Lamotrigine—epilepsy syndrome	9.55e-05	0.000515	CcSEcCtD
Sodium lauryl sulfate—Shock—Pregabalin—epilepsy syndrome	9.55e-05	0.000514	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	9.47e-05	0.00618	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	9.47e-05	0.00618	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	9.47e-05	0.00618	CbGpPWpGaD
Sodium lauryl sulfate—Tachycardia—Pregabalin—epilepsy syndrome	9.47e-05	0.00051	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Gabapentin—epilepsy syndrome	9.44e-05	0.000509	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.38e-05	0.000505	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Clonazepam—epilepsy syndrome	9.37e-05	0.000505	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Valproic Acid—epilepsy syndrome	9.33e-05	0.000502	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Phenytoin—epilepsy syndrome	9.31e-05	0.000501	CcSEcCtD
Sodium lauryl sulfate—Rash—Clonazepam—epilepsy syndrome	9.29e-05	0.000501	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Clonazepam—epilepsy syndrome	9.28e-05	0.0005	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Gabapentin—epilepsy syndrome	9.28e-05	0.0005	CcSEcCtD
Sodium lauryl sulfate—Nausea—Felbamate—epilepsy syndrome	9.28e-05	0.0005	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Oxcarbazepine—epilepsy syndrome	9.26e-05	0.000499	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Valproic Acid—epilepsy syndrome	9.25e-05	0.000498	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Gabapentin—epilepsy syndrome	9.25e-05	0.000498	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Pregabalin—epilepsy syndrome	9.25e-05	0.000498	CcSEcCtD
Sodium lauryl sulfate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—epilepsy syndrome	9.24e-05	0.00603	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Carbamazepine—epilepsy syndrome	9.24e-05	0.000498	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Lamotrigine—epilepsy syndrome	9.24e-05	0.000498	CcSEcCtD
Sodium lauryl sulfate—Headache—Clonazepam—epilepsy syndrome	9.23e-05	0.000497	CcSEcCtD
Sodium lauryl sulfate—Rash—Phenytoin—epilepsy syndrome	9.23e-05	0.000497	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Phenytoin—epilepsy syndrome	9.22e-05	0.000497	CcSEcCtD
Sodium lauryl sulfate—Rash—Oxcarbazepine—epilepsy syndrome	9.18e-05	0.000495	CcSEcCtD
Sodium lauryl sulfate—Constipation—Valproic Acid—epilepsy syndrome	9.18e-05	0.000494	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.17e-05	0.000494	CcSEcCtD
Sodium lauryl sulfate—Headache—Phenytoin—epilepsy syndrome	9.17e-05	0.000494	CcSEcCtD
Sodium lauryl sulfate—Headache—Oxcarbazepine—epilepsy syndrome	9.12e-05	0.000491	CcSEcCtD
Sodium lauryl sulfate—Nausea—Zonisamide—epilepsy syndrome	9.08e-05	0.000489	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Pregabalin—epilepsy syndrome	9.07e-05	0.000488	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Topiramate—epilepsy syndrome	9.04e-05	0.000487	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	9.03e-05	0.00589	CbGpPWpGaD
Sodium lauryl sulfate—Dysgeusia—Topiramate—epilepsy syndrome	8.98e-05	0.000484	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Lamotrigine—epilepsy syndrome	8.93e-05	0.000481	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.9e-05	0.000479	CcSEcCtD
Sodium lauryl sulfate—Oedema—Gabapentin—epilepsy syndrome	8.9e-05	0.000479	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Carbamazepine—epilepsy syndrome	8.88e-05	0.000479	CcSEcCtD
Sodium lauryl sulfate—Infection—Gabapentin—epilepsy syndrome	8.84e-05	0.000476	CcSEcCtD
Sodium lauryl sulfate—Rash—Carbamazepine—epilepsy syndrome	8.81e-05	0.000475	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Carbamazepine—epilepsy syndrome	8.8e-05	0.000474	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.78e-05	0.000473	CcSEcCtD
Sodium lauryl sulfate—Nausea—Clonazepam—epilepsy syndrome	8.75e-05	0.000472	CcSEcCtD
Sodium lauryl sulfate—Headache—Carbamazepine—epilepsy syndrome	8.75e-05	0.000472	CcSEcCtD
Sodium lauryl sulfate—Shock—Gabapentin—epilepsy syndrome	8.75e-05	0.000471	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Pregabalin—epilepsy syndrome	8.71e-05	0.000469	CcSEcCtD
Sodium lauryl sulfate—Nausea—Phenytoin—epilepsy syndrome	8.7e-05	0.000468	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Gabapentin—epilepsy syndrome	8.68e-05	0.000468	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Pregabalin—epilepsy syndrome	8.65e-05	0.000466	CcSEcCtD
Sodium lauryl sulfate—Nausea—Oxcarbazepine—epilepsy syndrome	8.65e-05	0.000466	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Topiramate—epilepsy syndrome	8.64e-05	0.000466	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.6e-05	0.000463	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Lamotrigine—epilepsy syndrome	8.59e-05	0.000462	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Valproic Acid—epilepsy syndrome	8.53e-05	0.000459	CcSEcCtD
Sodium lauryl sulfate—Rash—Lamotrigine—epilepsy syndrome	8.52e-05	0.000459	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Lamotrigine—epilepsy syndrome	8.51e-05	0.000458	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Valproic Acid—epilepsy syndrome	8.48e-05	0.000457	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Valproic Acid—epilepsy syndrome	8.48e-05	0.000457	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Gabapentin—epilepsy syndrome	8.48e-05	0.000457	CcSEcCtD
Sodium lauryl sulfate—Headache—Lamotrigine—epilepsy syndrome	8.46e-05	0.000456	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Pregabalin—epilepsy syndrome	8.43e-05	0.000454	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Pregabalin—epilepsy syndrome	8.36e-05	0.000451	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—PLAT—epilepsy syndrome	8.34e-05	0.00544	CbGpPWpGaD
Sodium lauryl sulfate—Hypotension—Gabapentin—epilepsy syndrome	8.31e-05	0.000448	CcSEcCtD
Sodium lauryl sulfate—Nausea—Carbamazepine—epilepsy syndrome	8.3e-05	0.000447	CcSEcCtD
Sodium lauryl sulfate—Constipation—Pregabalin—epilepsy syndrome	8.3e-05	0.000447	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—DOCK7—epilepsy syndrome	8.23e-05	0.00537	CbGpPWpGaD
Sodium lauryl sulfate—Syncope—Topiramate—epilepsy syndrome	8.22e-05	0.000443	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—CAT—epilepsy syndrome	8.13e-05	0.0053	CbGpPWpGaD
Sodium lauryl sulfate—Palpitations—Topiramate—epilepsy syndrome	8.1e-05	0.000437	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Topiramate—epilepsy syndrome	8.06e-05	0.000434	CcSEcCtD
Sodium lauryl sulfate—Nausea—Lamotrigine—epilepsy syndrome	8.02e-05	0.000432	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Gabapentin—epilepsy syndrome	7.99e-05	0.00043	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Topiramate—epilepsy syndrome	7.95e-05	0.000428	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.93e-05	0.000427	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Gabapentin—epilepsy syndrome	7.93e-05	0.000427	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—CRP—epilepsy syndrome	7.93e-05	0.00517	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.91e-05	0.000426	CcSEcCtD
Sodium lauryl sulfate—ALB—Lipid and lipoprotein metabolism—APOE—epilepsy syndrome	7.88e-05	0.00514	CbGpPWpGaD
Sodium lauryl sulfate—Chest pain—Topiramate—epilepsy syndrome	7.81e-05	0.000421	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Topiramate—epilepsy syndrome	7.78e-05	0.000419	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—APOE—epilepsy syndrome	7.76e-05	0.00506	CbGpPWpGaD
Sodium lauryl sulfate—Decreased appetite—Gabapentin—epilepsy syndrome	7.73e-05	0.000417	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Pregabalin—epilepsy syndrome	7.71e-05	0.000415	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Valproic Acid—epilepsy syndrome	7.7e-05	0.000415	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Gabapentin—epilepsy syndrome	7.67e-05	0.000413	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Pregabalin—epilepsy syndrome	7.67e-05	0.000413	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Pregabalin—epilepsy syndrome	7.67e-05	0.000413	CcSEcCtD
Sodium lauryl sulfate—Constipation—Gabapentin—epilepsy syndrome	7.61e-05	0.00041	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Valproic Acid—epilepsy syndrome	7.59e-05	0.000409	CcSEcCtD
Sodium lauryl sulfate—Oedema—Topiramate—epilepsy syndrome	7.48e-05	0.000403	CcSEcCtD
Sodium lauryl sulfate—Infection—Topiramate—epilepsy syndrome	7.44e-05	0.0004	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	7.36e-05	0.00481	CbGpPWpGaD
Sodium lauryl sulfate—Shock—Topiramate—epilepsy syndrome	7.36e-05	0.000397	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—GPX1—epilepsy syndrome	7.35e-05	0.0048	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Valproic Acid—epilepsy syndrome	7.34e-05	0.000395	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Topiramate—epilepsy syndrome	7.3e-05	0.000393	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.27e-05	0.000392	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Topiramate—epilepsy syndrome	7.24e-05	0.00039	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	7.18e-05	0.00468	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	7.18e-05	0.00468	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Pregabalin—epilepsy syndrome	7.15e-05	0.000385	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Topiramate—epilepsy syndrome	7.13e-05	0.000384	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	7.12e-05	0.00465	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	7.12e-05	0.00465	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Valproic Acid—epilepsy syndrome	7.1e-05	0.000382	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Gabapentin—epilepsy syndrome	7.07e-05	0.000381	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Gabapentin—epilepsy syndrome	7.03e-05	0.000379	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Gabapentin—epilepsy syndrome	7.03e-05	0.000379	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Topiramate—epilepsy syndrome	6.99e-05	0.000377	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Pregabalin—epilepsy syndrome	6.96e-05	0.000375	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Pregabalin—epilepsy syndrome	6.86e-05	0.00037	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Valproic Acid—epilepsy syndrome	6.82e-05	0.000368	CcSEcCtD
Sodium lauryl sulfate—Rash—Valproic Acid—epilepsy syndrome	6.77e-05	0.000364	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Valproic Acid—epilepsy syndrome	6.76e-05	0.000364	CcSEcCtD
Sodium lauryl sulfate—Headache—Valproic Acid—epilepsy syndrome	6.72e-05	0.000362	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Topiramate—epilepsy syndrome	6.72e-05	0.000362	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—LAMP2—epilepsy syndrome	6.71e-05	0.00438	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	6.68e-05	0.00436	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	6.68e-05	0.00436	CbGpPWpGaD
Sodium lauryl sulfate—Dyspnoea—Topiramate—epilepsy syndrome	6.67e-05	0.000359	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Pregabalin—epilepsy syndrome	6.64e-05	0.000358	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	6.56e-05	0.00428	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Gabapentin—epilepsy syndrome	6.55e-05	0.000353	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—FLNA—epilepsy syndrome	6.53e-05	0.00426	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—CCL2—epilepsy syndrome	6.52e-05	0.00426	CbGpPWpGaD
Sodium lauryl sulfate—Decreased appetite—Topiramate—epilepsy syndrome	6.51e-05	0.00035	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—CAT—epilepsy syndrome	6.46e-05	0.00421	CbGpPWpGaD
Sodium lauryl sulfate—Fatigue—Topiramate—epilepsy syndrome	6.45e-05	0.000348	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—CRP—epilepsy syndrome	6.45e-05	0.00421	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Pregabalin—epilepsy syndrome	6.42e-05	0.000346	CcSEcCtD
Sodium lauryl sulfate—Constipation—Topiramate—epilepsy syndrome	6.4e-05	0.000345	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Gabapentin—epilepsy syndrome	6.38e-05	0.000344	CcSEcCtD
Sodium lauryl sulfate—Nausea—Valproic Acid—epilepsy syndrome	6.37e-05	0.000343	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	6.35e-05	0.00414	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	6.35e-05	0.00414	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	6.35e-05	0.00414	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Gabapentin—epilepsy syndrome	6.29e-05	0.000339	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Pregabalin—epilepsy syndrome	6.17e-05	0.000332	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.12e-05	0.00033	CcSEcCtD
Sodium lauryl sulfate—Rash—Pregabalin—epilepsy syndrome	6.12e-05	0.000329	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Pregabalin—epilepsy syndrome	6.11e-05	0.000329	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	6.1e-05	0.00398	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Gabapentin—epilepsy syndrome	6.09e-05	0.000328	CcSEcCtD
Sodium lauryl sulfate—Headache—Pregabalin—epilepsy syndrome	6.08e-05	0.000327	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Topiramate—epilepsy syndrome	5.95e-05	0.00032	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Topiramate—epilepsy syndrome	5.92e-05	0.000319	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Topiramate—epilepsy syndrome	5.92e-05	0.000319	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Gabapentin—epilepsy syndrome	5.88e-05	0.000317	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—GPX1—epilepsy syndrome	5.84e-05	0.00381	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	5.81e-05	0.00379	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Pregabalin—epilepsy syndrome	5.76e-05	0.00031	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Gabapentin—epilepsy syndrome	5.66e-05	0.000305	CcSEcCtD
Sodium lauryl sulfate—Rash—Gabapentin—epilepsy syndrome	5.61e-05	0.000302	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Gabapentin—epilepsy syndrome	5.6e-05	0.000302	CcSEcCtD
Sodium lauryl sulfate—Headache—Gabapentin—epilepsy syndrome	5.57e-05	0.0003	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—SLC8A2—epilepsy syndrome	5.56e-05	0.00363	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Topiramate—epilepsy syndrome	5.51e-05	0.000297	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—RELA—epilepsy syndrome	5.47e-05	0.00357	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	5.37e-05	0.00351	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Topiramate—epilepsy syndrome	5.37e-05	0.000289	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—CCL2—epilepsy syndrome	5.31e-05	0.00346	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SLC8A3—epilepsy syndrome	5.3e-05	0.00346	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Topiramate—epilepsy syndrome	5.3e-05	0.000285	CcSEcCtD
Sodium lauryl sulfate—Nausea—Gabapentin—epilepsy syndrome	5.28e-05	0.000285	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	5.19e-05	0.00339	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PPIA—epilepsy syndrome	5.14e-05	0.00335	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—CRP—epilepsy syndrome	5.13e-05	0.00334	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Topiramate—epilepsy syndrome	5.12e-05	0.000276	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—COX3—epilepsy syndrome	5.08e-05	0.00331	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	5.06e-05	0.0033	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Topiramate—epilepsy syndrome	4.95e-05	0.000267	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—IL1B—epilepsy syndrome	4.95e-05	0.00323	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—epilepsy syndrome	4.86e-05	0.00317	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	4.81e-05	0.00314	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	4.81e-05	0.00314	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	4.81e-05	0.00314	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Topiramate—epilepsy syndrome	4.76e-05	0.000256	CcSEcCtD
Sodium lauryl sulfate—Rash—Topiramate—epilepsy syndrome	4.72e-05	0.000254	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Topiramate—epilepsy syndrome	4.71e-05	0.000254	CcSEcCtD
Sodium lauryl sulfate—Headache—Topiramate—epilepsy syndrome	4.69e-05	0.000253	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.63e-05	0.00302	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	4.62e-05	0.00302	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	4.59e-05	0.003	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	4.59e-05	0.003	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.46e-05	0.00291	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—RELA—epilepsy syndrome	4.45e-05	0.00291	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Topiramate—epilepsy syndrome	4.45e-05	0.000239	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—CCL2—epilepsy syndrome	4.22e-05	0.00275	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	4.05e-05	0.00264	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL1B—epilepsy syndrome	4.03e-05	0.00263	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—ADRA2A—epilepsy syndrome	4.01e-05	0.00262	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CA13—epilepsy syndrome	3.92e-05	0.00256	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—APOD—epilepsy syndrome	3.74e-05	0.00244	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	3.65e-05	0.00238	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	3.65e-05	0.00238	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—TNF—epilepsy syndrome	3.59e-05	0.00234	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TEK—epilepsy syndrome	3.58e-05	0.00234	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—RELA—epilepsy syndrome	3.54e-05	0.00231	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—AKT3—epilepsy syndrome	3.51e-05	0.00229	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	3.48e-05	0.00227	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	3.44e-05	0.00224	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—FLNA—epilepsy syndrome	3.37e-05	0.0022	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	3.34e-05	0.00218	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	3.34e-05	0.00218	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	3.34e-05	0.00218	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	3.34e-05	0.00218	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	3.34e-05	0.00218	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	3.21e-05	0.00209	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—IL1B—epilepsy syndrome	3.2e-05	0.00209	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—KCNMA1—epilepsy syndrome	3.19e-05	0.00208	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.16e-05	0.00206	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SLC8A1—epilepsy syndrome	3.15e-05	0.00206	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	3.1e-05	0.00202	CbGpPWpGaD
Sodium lauryl sulfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	3.01e-05	0.00196	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GLUD1—epilepsy syndrome	2.97e-05	0.00194	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ADK—epilepsy syndrome	2.97e-05	0.00194	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—FAR1—epilepsy syndrome	2.97e-05	0.00194	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PDXK—epilepsy syndrome	2.97e-05	0.00194	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CERS1—epilepsy syndrome	2.97e-05	0.00194	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—L2HGDH—epilepsy syndrome	2.97e-05	0.00194	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.96e-05	0.00193	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	2.92e-05	0.00191	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—TNF—epilepsy syndrome	2.92e-05	0.00191	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.92e-05	0.0019	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	2.85e-05	0.00186	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.84e-05	0.00185	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	2.78e-05	0.00182	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	2.74e-05	0.00179	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.73e-05	0.00178	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.73e-05	0.00178	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NHLRC1—epilepsy syndrome	2.72e-05	0.00177	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GAMT—epilepsy syndrome	2.72e-05	0.00177	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PNPO—epilepsy syndrome	2.72e-05	0.00177	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—EPM2A—epilepsy syndrome	2.72e-05	0.00177	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PPIA—epilepsy syndrome	2.65e-05	0.00173	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.64e-05	0.00172	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.64e-05	0.00172	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—QDPR—epilepsy syndrome	2.53e-05	0.00165	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CA4—epilepsy syndrome	2.53e-05	0.00165	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.53e-05	0.00165	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ATP2A2—epilepsy syndrome	2.42e-05	0.00158	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—COX3—epilepsy syndrome	2.38e-05	0.00155	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.35e-05	0.00153	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ITGA2—epilepsy syndrome	2.35e-05	0.00153	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.32e-05	0.00151	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	2.26e-05	0.00148	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PFKL—epilepsy syndrome	2.25e-05	0.00147	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLCO1A2—epilepsy syndrome	2.25e-05	0.00147	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CACNA2D2—epilepsy syndrome	2.25e-05	0.00147	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—KCNB1—epilepsy syndrome	2.25e-05	0.00147	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC6A8—epilepsy syndrome	2.25e-05	0.00147	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.2e-05	0.00144	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.19e-05	0.00143	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.15e-05	0.0014	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.09e-05	0.00137	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ADRA2A—epilepsy syndrome	2.07e-05	0.00135	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NEU1—epilepsy syndrome	2.06e-05	0.00135	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—UPB1—epilepsy syndrome	2.06e-05	0.00135	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ATIC—epilepsy syndrome	2.06e-05	0.00135	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PLAT—epilepsy syndrome	2.06e-05	0.00134	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HSD17B4—epilepsy syndrome	1.98e-05	0.00129	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—NOS1—epilepsy syndrome	1.93e-05	0.00126	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GBE1—epilepsy syndrome	1.92e-05	0.00125	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PPP1R3C—epilepsy syndrome	1.92e-05	0.00125	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.87e-05	0.00122	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—AKT3—epilepsy syndrome	1.81e-05	0.00118	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ASAH1—epilepsy syndrome	1.8e-05	0.00118	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PLAUR—epilepsy syndrome	1.79e-05	0.00117	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.78e-05	0.00116	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—STXBP1—epilepsy syndrome	1.75e-05	0.00114	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NT5E—epilepsy syndrome	1.71e-05	0.00111	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ALAD—epilepsy syndrome	1.71e-05	0.00111	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.7e-05	0.00111	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CDC42—epilepsy syndrome	1.65e-05	0.00108	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CACNA1A—epilepsy syndrome	1.63e-05	0.00106	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ALDH7A1—epilepsy syndrome	1.63e-05	0.00106	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ST3GAL3—epilepsy syndrome	1.59e-05	0.00104	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ADSL—epilepsy syndrome	1.56e-05	0.00102	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GLUL—epilepsy syndrome	1.53e-05	0.001	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CACNA1D—epilepsy syndrome	1.5e-05	0.000981	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—FYN—epilepsy syndrome	1.47e-05	0.00096	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—YWHAZ—epilepsy syndrome	1.41e-05	0.000923	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—TXNRD1—epilepsy syndrome	1.41e-05	0.000918	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.4e-05	0.000912	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.39e-05	0.000904	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AQP1—epilepsy syndrome	1.37e-05	0.000891	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.34e-05	0.000875	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.33e-05	0.000868	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.31e-05	0.000856	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.3e-05	0.000846	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PLAU—epilepsy syndrome	1.26e-05	0.000819	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.23e-05	0.000806	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CHRM3—epilepsy syndrome	1.23e-05	0.000806	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.17e-05	0.000762	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—NOS2—epilepsy syndrome	1.15e-05	0.000753	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.15e-05	0.00075	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.13e-05	0.000735	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ABCG2—epilepsy syndrome	1.01e-05	0.000657	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP2C19—epilepsy syndrome	9.81e-06	0.00064	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP11A1—epilepsy syndrome	9.75e-06	0.000636	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.68e-06	0.000632	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP2D6—epilepsy syndrome	8.8e-06	0.000574	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ADRA2A—epilepsy syndrome	8.38e-06	0.000547	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—BCHE—epilepsy syndrome	8.34e-06	0.000544	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	8.27e-06	0.00054	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC2A1—epilepsy syndrome	7.96e-06	0.000519	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PLCB1—epilepsy syndrome	7.87e-06	0.000514	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—TH—epilepsy syndrome	7.84e-06	0.000512	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.72e-06	0.000504	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SRC—epilepsy syndrome	6.86e-06	0.000448	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—VEGFA—epilepsy syndrome	6.68e-06	0.000436	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HMOX1—epilepsy syndrome	6.55e-06	0.000427	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CAT—epilepsy syndrome	6.46e-06	0.000421	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ABCB1—epilepsy syndrome	6.28e-06	0.00041	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GPX1—epilepsy syndrome	5.84e-06	0.000381	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AGT—epilepsy syndrome	5.12e-06	0.000334	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—APOE—epilepsy syndrome	5.02e-06	0.000327	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—POMC—epilepsy syndrome	4.31e-06	0.000281	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—AKT1—epilepsy syndrome	4.26e-06	0.000278	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PTGS2—epilepsy syndrome	3.44e-06	0.000224	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AKT1—epilepsy syndrome	1.73e-06	0.000113	CbGpPWpGaD
